🇺🇸 FDA
Patent

US 7312301

Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof

granted A61KA61K47/60A61P

Quick answer

US patent 7312301 (Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof) held by Nektar Therapeutics AL, Corporation expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics AL, Corporation
Grant date
Tue Dec 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K47/60, A61P, A61P29/00